Cargando…
Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni
Campylobacter jejuni (C. jejuni) is one of the major pathogens contributing to the enteritis in humans. Infection can lead to numerous complications, including but not limited to Guillain-Barre syndrome, reactive arthritis, and Reiter’s syndrome. Over the past two decades, joint efforts have been ma...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793626/ https://www.ncbi.nlm.nih.gov/pubmed/35095793 http://dx.doi.org/10.3389/fmicb.2021.773697 |
_version_ | 1784640647505903616 |
---|---|
author | Lou, Hongqiang Li, Xusheng Sheng, Xiusheng Fang, Shuiqin Wan, Shaoye Sun, Aihua Chen, Haohao |
author_facet | Lou, Hongqiang Li, Xusheng Sheng, Xiusheng Fang, Shuiqin Wan, Shaoye Sun, Aihua Chen, Haohao |
author_sort | Lou, Hongqiang |
collection | PubMed |
description | Campylobacter jejuni (C. jejuni) is one of the major pathogens contributing to the enteritis in humans. Infection can lead to numerous complications, including but not limited to Guillain-Barre syndrome, reactive arthritis, and Reiter’s syndrome. Over the past two decades, joint efforts have been made toward developing a proper strategy of limiting the transmission of C. jejuni to humans. Nevertheless, except for biosecurity measures, no available vaccine has been developed so far. Judging from the research findings, Omp18, AhpC outer membrane protein, and FlgH flagellin subunits of C. jejuni could be adopted as surface protein antigens of C. jejuni for screening dominant epitope thanks to their strong antigenicity, expression of varying strains, and conservative sequence. In this study, bioinformatics technology was adopted to analyze the T-B antigenic epitopes of Omp18, AhpC, and FlgH in C. jejuni strain NCTC11168. Both ELISA and Western Blot methods were adopted to screen the dominant T-B combined epitope. GGS (GGCGGTAGC) sequence was adopted to connect the dominant T-B combined epitope peptides and to construct the prokaryotic expression system of tandem repeats of antigenic epitope peptides. The mouse infection model was adopted to assess the immunoprotective effect imposed by the trivalent T-B combined with antigen epitope peptide based on Omp18/AhpC/FlgH. In this study, a tandem epitope AhpC-2/Omp18-1/FlgH-1 was developed, which was composed of three epitopes and could effectively enhance the stability and antigenicity of the epitope while preserving its structure. The immunization of BALB/c mice with a tandem epitope could induce protective immunity accompanied by the generation of IgG2a antibody response through the in vitro synthesis of IFN-γ cytokines. Judging from the results of immune protection experiments, the colonization of C. jejuni declined to a significant extent, and it was expected that AhpC-2/Omp18-1/FlgH-1 could be adopted as a candidate antigen for genetic engineering vaccine of C. jejuni MAP. |
format | Online Article Text |
id | pubmed-8793626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87936262022-01-28 Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni Lou, Hongqiang Li, Xusheng Sheng, Xiusheng Fang, Shuiqin Wan, Shaoye Sun, Aihua Chen, Haohao Front Microbiol Microbiology Campylobacter jejuni (C. jejuni) is one of the major pathogens contributing to the enteritis in humans. Infection can lead to numerous complications, including but not limited to Guillain-Barre syndrome, reactive arthritis, and Reiter’s syndrome. Over the past two decades, joint efforts have been made toward developing a proper strategy of limiting the transmission of C. jejuni to humans. Nevertheless, except for biosecurity measures, no available vaccine has been developed so far. Judging from the research findings, Omp18, AhpC outer membrane protein, and FlgH flagellin subunits of C. jejuni could be adopted as surface protein antigens of C. jejuni for screening dominant epitope thanks to their strong antigenicity, expression of varying strains, and conservative sequence. In this study, bioinformatics technology was adopted to analyze the T-B antigenic epitopes of Omp18, AhpC, and FlgH in C. jejuni strain NCTC11168. Both ELISA and Western Blot methods were adopted to screen the dominant T-B combined epitope. GGS (GGCGGTAGC) sequence was adopted to connect the dominant T-B combined epitope peptides and to construct the prokaryotic expression system of tandem repeats of antigenic epitope peptides. The mouse infection model was adopted to assess the immunoprotective effect imposed by the trivalent T-B combined with antigen epitope peptide based on Omp18/AhpC/FlgH. In this study, a tandem epitope AhpC-2/Omp18-1/FlgH-1 was developed, which was composed of three epitopes and could effectively enhance the stability and antigenicity of the epitope while preserving its structure. The immunization of BALB/c mice with a tandem epitope could induce protective immunity accompanied by the generation of IgG2a antibody response through the in vitro synthesis of IFN-γ cytokines. Judging from the results of immune protection experiments, the colonization of C. jejuni declined to a significant extent, and it was expected that AhpC-2/Omp18-1/FlgH-1 could be adopted as a candidate antigen for genetic engineering vaccine of C. jejuni MAP. Frontiers Media S.A. 2022-01-13 /pmc/articles/PMC8793626/ /pubmed/35095793 http://dx.doi.org/10.3389/fmicb.2021.773697 Text en Copyright © 2022 Lou, Li, Sheng, Fang, Wan, Sun and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Lou, Hongqiang Li, Xusheng Sheng, Xiusheng Fang, Shuiqin Wan, Shaoye Sun, Aihua Chen, Haohao Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni |
title | Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni |
title_full | Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni |
title_fullStr | Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni |
title_full_unstemmed | Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni |
title_short | Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni |
title_sort | development of a trivalent construct omp18/ahpc/flgh multi epitope peptide vaccine against campylobacter jejuni |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793626/ https://www.ncbi.nlm.nih.gov/pubmed/35095793 http://dx.doi.org/10.3389/fmicb.2021.773697 |
work_keys_str_mv | AT louhongqiang developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni AT lixusheng developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni AT shengxiusheng developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni AT fangshuiqin developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni AT wanshaoye developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni AT sunaihua developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni AT chenhaohao developmentofatrivalentconstructomp18ahpcflghmultiepitopepeptidevaccineagainstcampylobacterjejuni |